Oracle Corporation (NYSE:ORCL) Shares Purchased by Novem Group

Novem Group boosted its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 58.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,659 shares of the enterprise software provider's stock after acquiring an additional 1,720 shares during the period. Novem Group's holdings in Oracle were worth $651,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Oracle in the 4th quarter worth $2,216,314,000. Raymond James Financial Inc. acquired a new position in shares of Oracle during the fourth quarter worth about $930,095,000. GAMMA Investing LLC raised its holdings in Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after purchasing an additional 4,723,631 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after purchasing an additional 2,350,448 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in Oracle by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after purchasing an additional 2,296,069 shares in the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle Price Performance

Shares of NYSE ORCL traded up $7.41 during trading on Friday, reaching $237.39. The company had a trading volume of 18,441,376 shares, compared to its average volume of 10,140,491. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 4.07. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $237.99. The stock has a 50-day moving average price of $176.16 and a two-hundred day moving average price of $163.79. The stock has a market capitalization of $666.79 billion, a PE ratio of 54.70, a price-to-earnings-growth ratio of 3.44 and a beta of 1.39.

Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. The firm had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm's revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.63 EPS. As a group, sell-side analysts predict that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Thursday, July 10th. Oracle's dividend payout ratio is presently 46.08%.

Insider Activity

In related news, insider Clayton M. Magouyrk sold 15,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the sale, the insider owned 60,722 shares in the company, valued at approximately $13,000,580.20. This trade represents a 19.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Leon E. Panetta sold 17,500 shares of the business's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the transaction, the director owned 58,090 shares of the company's stock, valued at $8,785,531.60. This trade represents a 23.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 440,366 shares of company stock worth $83,103,603. Corporate insiders own 42.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Raymond James Financial reissued a "strong-buy" rating on shares of Oracle in a research note on Wednesday, June 18th. TD Cowen increased their price objective on Oracle from $250.00 to $275.00 and gave the stock a "buy" rating in a research report on Thursday. Cowen reissued a "buy" rating on shares of Oracle in a report on Thursday, June 12th. Jefferies Financial Group upped their price target on shares of Oracle from $190.00 to $200.00 and gave the stock a "buy" rating in a research note on Monday, June 9th. Finally, Royal Bank Of Canada increased their price target on shares of Oracle from $145.00 to $195.00 and gave the company a "sector perform" rating in a report on Thursday, June 12th. Ten equities research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Oracle currently has an average rating of "Moderate Buy" and a consensus target price of $204.15.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.